Chemical and Pharmaceutical Bulletin · 2012 · 10 citations · 17 references
MedicinePharmacokineticsPharmacologyDrug ClearanceDrug DiscoveryDrug MetabolismCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug DispositionDrug-metabolizing EnzymesHepatic Drug MetabolismCyp2c19 Drug MetabolismCyp2d6 Drug MetabolismCytochrome P450 2D6Cytochrome P450 Drug MetabolismCytochrome P450 KineticsHepatic Intrinsic ClearanceMaximum Reaction VelocityMichaelis Constant
The investigation of cytochrome P450 (CYP) mediated metabolism reactions by determination of enzyme kinetic parameters, Michaelis constant (K(m)), maximum reaction velocity (V(max)), and intrinsic clearance (CL(int)) is important aspects in discovery and development of drugs. The kinetic parameters can be used to predict the clearance prior to human administration and for better understanding the mechanism of clearance in vivo. In this study, the metabolic activities of three major hepatic CYP isoforms (2C19, 2D6, and 3A4) were investigated on structurally different central nervous system (CNS) acting drugs, amitriptyline, fluphenazine, and dothiepin. By using our novel in vitro evaluation system, we could compare the kinetic parameters for the metabolism of fluphenazine and dothiepin for the first time. Comparing CL(int) values thus obtained, we concluded that 2C19 could be predominant for metabolic activity on tricyclic antidepressants as expected, but not on phenothiazine-related antipsychotic drugs. Since the metabolism of CNS drugs is susceptible to single nucleotide polymorphisms of human gene, our results suggest that phenothiazine could be an alternative to clinical application of CNS drugs.
17
Henry W. Strobel, Anthony Y.H. Lu, Joanne K. Heidema et al. · Journal of Biological Chemistry · 1970 · 463 citations · Full text
ADMET—turning chemicals into drugs
John Hodgson · Nature Biotechnology · 2001 · 427 citations
Werner Steimer, Konstanze Zöpf, Silvia von Amelunxen et al. · Clinical Chemistry · 2004 · 141 citations · Full text